Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoprotein
暂无分享,去创建一个
F. Baas | R. Arceci | T. Tsuruo | P. Borst | I. Roninson | E. Mechetner | A. Schinkel | E. Wagenaar | J. Smit | M. Dollé | Martijn Dollé
[1] G. Rudenko,et al. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein. , 1993, The Journal of biological chemistry.
[2] T. Tsuruo,et al. Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. , 1993, The Journal of biological chemistry.
[3] F. Baas,et al. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. , 1993, Cancer research.
[4] I. Roninson,et al. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Mackensen,et al. Reversal of Vinca alkaloid resistance by anti-P-glycoprotein monoclonal antibody HYB-241 in a human tumor xenograft. , 1992, Cancer research.
[6] V. Ling,et al. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. , 1991, The New England journal of medicine.
[7] T. Tsuruo,et al. Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody. , 1991, Journal of the National Cancer Institute.
[8] T. Tsuruo,et al. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] P. Borst,et al. Multidrug resistance mediated by P-glycoproteins. , 1991, Seminars in cancer biology.
[10] P. Borst,et al. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. , 1991, Cancer research.
[11] T. Tsuruo,et al. Expression of the multiple drug resistance gene (mdr‐1) and epitope masking in chronic lymphatic leukaemia , 1990, British journal of haematology.
[12] M. Melamed,et al. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] A. M. van der Bliek,et al. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. , 1990, Cancer research.
[14] J. Gariépy,et al. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] I. Pastan,et al. Expression of Multidrug Resistance Gene in Human Cancers , 1989 .
[16] J. Endicott,et al. The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.
[17] M. Melamed,et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. M. van der Bliek,et al. Sequence of mdr3 cDNA encoding a human P-glycoprotein. , 1988, Gene.
[19] J. Bulte,et al. Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance , 1988, International journal of cancer.
[20] D. Housman,et al. Cloning and characterization of a second member of the mouse mdr gene family , 1988, Molecular and cellular biology.
[21] I. Pastan,et al. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Childs,et al. Carbohydrates as antigenic determinants of glycoproteins. , 1987, The Biochemical journal.
[24] I. Pastan,et al. A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Tsuruo,et al. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Ling,et al. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies , 1985, Nature.
[27] B. Giovanella,et al. Exceptional lethality for nude mice of cells derived from a primary human melanoma. , 1985, Cancer research.